Shenzhen New Industries Biomedical Engineering Co., Ltd. (SHE:300832)

China flag China · Delayed Price · Currency is CNY
52.25
+1.70 (3.36%)
Mar 3, 2026, 3:04 PM CST
-15.73%
Market Cap 39.72B
Revenue (ttm) 4.55B
Net Income (ttm) 1.65B
Shares Out 785.72M
EPS (ttm) 2.10
PE Ratio 24.08
Forward PE 21.59
Dividend 1.30 (2.48%)
Ex-Dividend Date May 28, 2025
Volume 7,565,837
Average Volume 4,855,918
Open 51.98
Previous Close 50.55
Day's Range 51.07 - 53.08
52-Week Range 49.01 - 71.51
Beta -0.32
RSI 25.71
Earnings Date Apr 28, 2026

About SHE:300832

Shenzhen New Industries Biomedical Engineering Co., Ltd., engages in the research, development, production, and sale of clinical laboratory instruments and in vitro diagnostic reagents to hospitals in China and internationally. It offers immunoassay machine, biochemistry/electrolyte, integrated system, lab automation, molecular diagnostics, hemolumi and rapid test solutions. The company was founded in 1995 and is based in Shenzhen, China. [Read more]

Industry Medical Devices
Sector Healthcare
Founded 1995
Employees 2,841
Stock Exchange Shenzhen Stock Exchange
Ticker Symbol 300832
Full Company Profile

Financial Performance

In 2024, SHE:300832's revenue was 4.54 billion, an increase of 15.41% compared to the previous year's 3.93 billion. Earnings were 1.83 billion, an increase of 10.57%.

Financial Statements

News

There is no news available yet.